U.S. outpatient prescriptions for hydroxychloroquine and ivermectin increased 2- to 10-fold above pre-pandemic rates, respectively, to treat COVID-19, despite strong evidence disproving their ...

A federal commission to examine U.S. chronic disease could undercut real treatment for kids with depression, ADHD and other ...

Health Affairs' Jeff Byers welcomes Senior Editor Kathleen Haddad back to the program to discuss two recent reports exploring the impacts of private equity on the US health care system.

However, a newer lupus drug, anifrolumab (brand name Saphnelo), has shown promising results in reducing organ damage, ...